The meeting, which helps the FDA give guidance to vaccine makers on which flu strains to target, is the second to be ...
Verve offered few details on the early end of a collaboration the companies inked in 2022, saying only that Vertex cited “changing priorities.” ...
Woven Health Collective elevates clients’ science, engages the right stakeholders, and magnifies success with a harmonized and highly specialized approach across key areas. All services are backed by ...
The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...
The British drugmaker claimed study success in a first-line setting in breast cancer. Elsewhere, Rezdiffra sales continued to ...
The funding comes as Eikon, run by former Merck research chief Roger Perlmutter, has started a Phase 3 trial testing one of ...
While announcing billions of dollars in new U.S. investments, company chief David Ricks called for an extension of 2017 tax ...
The Trump administration’s plans to reduce NIH grant funding could have long-term consequences for the U.S. drug industry, ...
An industry source said “most, if not all” of the people at CDRH who were recently dismissed are now being asked to return.
"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...
Ten of 11 children born with a rare form of congenital hearing loss experienced improvements after receiving the company’s ...
Telehealth provider Hims & Hers said it will tell consumers they need to seek “alternative options on the commercial dosing,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results